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Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, SwitzerlandABSTRACT The understanding of the molecular mechanisms underlying protein self-assembly and of their dependence on
solvent composition has implications in a large number of biological and biotechnological systems. In this work, we characterize
the aggregation process of human insulin at acidic pH in the presence of sulfate ions using a combination of Thioflavin T fluo-
rescence, dynamic light scattering, size exclusion chromatography, Fourier transform infrared spectroscopy, and transmission
electron microscopy. It is found that the increase of sulfate concentration inhibits the conversion of insulin molecules into aggre-
gates by modifying the aggregation pathway. At low sulfate concentrations (0–5 mM) insulin forms amyloid fibrils following the
nucleated polymerization mechanism commonly observed under acidic conditions in the presence of monovalent anions. When
the sulfate concentration is increased above 5mM, the sulfate anion induces the salting-out of ~18–20% of insulin molecules into
reversible amorphous aggregates, which retain a large content of a-helix structures. During time these aggregates undergo
structure rearrangements into b-sheet structures, which are able to recruit monomers and bind to the Thioflavin T dye. The alter-
native aggregation mechanism observed at large sulfate concentrations is characterized by a larger activation energy and leads
to more polymorphic structures with respect to the self-assembly in the presence of chloride ions. The system shown in this work
represents a case where amorphous aggregates on pathway to the formation of structures with amyloid features could be
detected and analyzed.INTRODUCTIONIn the last decades, the interest in understanding the molec-
ular mechanisms responsible for protein self-assembling
has increased significantly due to the large number of impli-
cations in life sciences and technology. Examples range
from the aberrant aggregation of peptides and proteins
involved in several neurodegenerative diseases (1), to the
stability of protein solutions in food and pharmaceutical
industry (2–4) as well as the engineering of mechanically
and chemically stable biomaterials (5).
A large number of aggregation pathways and aggregate
structures has been observed depending on the specific
protein and the environmental conditions under consider-
ation: many proteins under suitable conditions are able to
self-assemble into regular fibrillar structures known as
amyloids (6–10), although in other systems proteins aggre-
gate into amorphous precipitates (11–13). In addition,
different aggregation pathways may occur simultaneously,
thereby leading to a heterogeneous composition of the final
products.
One of the most relevant external factors affecting protein
aggregation pathways and aggregate morphologies is the
buffer composition. Ions and other cosolutes, such as sugars,Submitted December 4, 2013, and accepted for publication May 6, 2014.
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molecular interactions via a combination of several effects
such as charge screening, ion binding, preferential exclu-
sion, and dipole interactions, therefore affecting the protein
secondary and quaternary structure (14–19) as well as
the individual microscopic events underlying the aggrega-
tion process (20). Peculiar effects such as ion specificity
and restabilization behavior at large salt concentrations
have been observed in the aggregation of many different
proteins, ranging from short peptides to globular multido-
main proteins (21–25). In the amyloid field, specific ion
effects have been observed for instance in the aggregation
of the Ab peptide (26), a-synuclein (27), islet amyloid poly-
peptide (28), prion protein (29), and HypF-N (30). The pro-
pensity of the different ions to induce protein aggregation is
commonly related to either the electroselectivity or the Hof-
meister series, a ranking that has been observed in a broad
range of phenomena in physics and chemistry (31). Howev-
er, the exact order of the effectiveness of different ions in
promoting aggregation is strongly dependent on the pH
value, the salt concentration, and the specific protein under
consideration.
In this study, we concentrate our attention on the effect of
sulfate anion on the fibrillization process of human insulin
under acidic conditions. Sulfate is a kosmotropic anion
that stabilizes protein structure and reduces protein solubil-
ity in solution (29). In the form of ammonium salt, sulfate is
one of the most common anions used for inducing saltinghttp://dx.doi.org/10.1016/j.bpj.2014.05.030
198 Owczarz and Arosioout of proteins in crystallography and purification processes
(32,33). Although the effect on the precipitation of native
proteins is well characterized, the effect of sulfate on nonna-
tive protein aggregation behavior is more complex. On one
hand, the salting-out property promotes aggregation due to
the decrease of the total amount of exposed surface that
accompanies the formation of the aggregates; on the other
hand, the kosmotropic nature of the anion stabilizes the
protein structure under nonnative conditions, therefore
reducing the formation of nonnative aggregation-prone con-
formations. In addition, the divalency of the anion confers
peculiar properties in terms of charge screening, anion bind-
ing, and salt bridge formation. The overimposition of the
different electrostatic effects can either promote (34–36)
or inhibit (37) the protein aggregation propensity. In the
case of an IgG2 monoclonal antibody, we have recently
reported a maximum of the aggregation propensity as a
function of sulfate concentration (22).
The delicate balance between the different sulfate proper-
ties modulates not only the protein aggregation propensity,
but also the morphology of the final aggregates. When
monovalent anions are replaced by sulfate, either longer
fibrils or, on the contrary, amorphous aggregates and shorter
fibrils are observed (20,36,38). Sulfate can also promote
fibril lateral aggregation and increase fibril stability (30).
The different effect depends strongly on the anion concen-
tration and the protein primary sequence. For instance, sul-
fate has been found to promote the fibril formation of the
EAK16-II peptide (39), and to disrupt the regular fibrillar
structure of the EMK16-II peptide (40).
The understanding of the complex effect of sulfate anion
on protein aggregation may represent, to our knowledge,
a first step toward the fundamental rationalization of the
even more complex interactions between proteins and
sulfonate biomacromolecules, such as glycosaminoglycans.
These physiologically relevant components are polyelec-
trolyte macromolecules that are involved in the in vivo
aggregation propensity of several amyloidogenic proteins
(41–46).
In this work, we analyze the effect of sulfate on the aggre-
gation behavior of human insulin, a hormone produced in
pancreatic b cells and responsible for the metabolism of
glucose (47). Insulin is one of the therapeutic proteins
with the largest production volume due to the use as regu-
lator of the level of sugar in the blood of people affected
by diabetes (47). Insulin is well known to form amyloid
fibrils characterized by large b-sheet content under destabi-
lizing conditions such as low pH and high temperature
(38,47–50). Several biophysical studies investigated the
molecular pathway underlying the fibril formation process
using monovalent anions, typically chloride (9,20,51–55).
When chloride is replaced by sulfate, destabilizing and sta-
bilizing effects have been reported at low and high ionic
strength, respectively (56), and a shortening of the fibril
length has been observed (38).Biophysical Journal 107(1) 197–207Here, we investigate whether the changes in the kinetics
and in the aggregate morphology observed when chloride
is replaced by sulfate are connected to a change in the aggre-
gation mechanism. In particular, we characterize in detail
the aggregation of insulin in the presence of sodium sulfate
under conditions where formation of amyloid fibrils is
commonly observed, i.e., 25 mM HCl at pH 1.6 and 60C
under quiescent conditions (57). At this pH value positive
charges are largely dominating on the protein surface, and
therefore the specific effect of monovalent cations can be
considered negligible with respect to the anion effect.
Indeed, the negligible effect of monovalent cations at low
pH has been observed previously with other proteins
(22,30). In addition, Hofmeister effects are normally domi-
nated by anions with respect to cations.
The study is performed in parallel with the investigation
of the aggregation behavior in the presence of sodium chlo-
ride, to allow the comparison with the well-known behavior
reported in the literature (9,56,58–61).
We investigated the aggregation kinetics and the
aggregate morphology using a combination of Thioflavin
T (ThT) fluorescence, dynamic light scattering (DLS),
size exclusion chromatography (SEC), Fourier transform
infrared spectroscopy (FTIR), and transmission electron
microscopy (TEM). We show that at concentrations larger
than 5 mM sulfate ions induce an alternative aggregation
pathway with respect to chloride ions. This alternative
process involves an initial precipitation of amorphous ag-
gregates, which during time undergo structural rearrange-
ments into b-sheet structures, which exhibit features of
amyloid fibrils. This study represents a relevant example
where amorphous intermediates on-pathway to b-sheet-
rich structures could be isolated and characterized.MATERIALS AND METHODS
Materials and aggregation conditions
Human insulin was kindly donated by Novo Nordisk (Bagsvaerd,
Denmark). Insulin solutions in the concentration range 0.5–5 g/L
(86–860 mM) were freshly prepared before each experiment by dissolving
insulin powder in 25 mM HCl solution (Fluka Chemika, Buchs,
Switzerland) at pH 1.6 with 100 mM sodium chloride (VWR International
BVBA, Leuven, Belgium) or 100 mM sodium sulfate (Merck kGaA,
Darmstadt, Germany). To remove potential seeds, before the aggregation
studies the solutions were filtered by low protein binding hydrophilic
LCR, Millex-LG syringe filters with 200 nm cut-off membrane (Merck
Millipore, Merck KGaA, Darmstadt, Germany). The protein concentration
after filtration was measured by ultraviolet absorbance at 280 nm. Aggre-
gation was induced by incubating the protein solutions in the temperature
range from 57 to 63C.
It is known that the insulin fibrillation process can be affected by the
presence of surfaces, in particular by hydrophobic surfaces (63). To probe
for the presence of possible artifacts induced by this effect, we monitored
the aggregation of insulin solutions incubated in cuvettes or tubes made of
different materials (glass, polystyrene, polypropylene, and polymetylme-
tacrylate) using different solution volumes. No significant difference
was observed under the different conditions, indicating that, at least under
Sulfate Delays Insulin Aggregation 199the investigated conditions, both the material of the container and the total
sample volume do not affect the conclusions of this work.ThT fluorescence assay
ThT (Sigma-Aldrich GmbH, Steinheim, Germany) fluorescence was
measured in a 96-well plate (96 Isoplate, Perkin Elmer, Waltham, MA)
using an EnSpire 2300 Multilabel Reader fluorometer (Perkin Elmer).
10 mM ThT was added to threefold diluted samples taken at different
time points and emission fluorescence values were measured at 485 nm
after excitation at 450 nm.
On-line kinetic experiments were performed by incubating the protein
solution in the presence of 10 mM ThT and monitoring the fluorescence
signal during aggregation. No significant difference was observed between
the off-line and the on-line kinetics (data reported in the Supporting
Material, Fig. S1).DLS
DLS measurements were performed on-line using a Zetasizer Nano
(Malvern, Worcestershire, United Kingdom), operating in the backscat-
tering mode at a fixed angle of 173 with a laser beam with wavelength
of 633 nm.SEC coupled with multiangle static light
scattering (MALS)
SEC analysis was performed with a Superdex Peptide 10/300 GL, 10 mm
300 mm size-exclusion column (GE Healthcare, Uppsala, Sweden) assem-
bled on a Agilent 1100 series HPLC unit (Santa Clara, CA). Each sample
was eluted for 70 min at a constant flow rate of 0.4 mL/min using as mobile
phase 10 mM HCl solution at pH 2.0. The pH of the mobile phase was
slightly greater than the pH of the analyzed samples (pH ¼ 1.6) to avoid
damage of the equipment. Ultraviolet absorbance was detected at
280 nm. To evaluate the amount of residual soluble insulin during the
aggregation process, protein samples were centrifuged for 15 min at
10,000 rpm to precipitate the aggregates, and 40 ml aliquots of the superna-
tant were injected into the column after filtration by low protein binding
hydrophilic LCR, Millex-LG syringe filters with 200 nm cut-off membrane
(Merck Millipore).
MALS of fractionated samples eluting from the SEC column was
measured on-line by a Wyatt light scattering detector (Wyatt, Dernbach,
Germany) with a laser beam with a wavelength of 658 nm and scattering
angles from 14 to 163.FTIR
Hydrated thin film attenuated total reflectance Fourier transform infrared
spectroscopy (ATR-FTIR) measurements were performed on a Nicolet
Nexus 870 FTIR ESP instrument equipped with a ATR Nicolet Omni-
Sampler device (Nicolet, Madison, WI). Aliquots of 10 mL were spotted
on the crystal surface and dried under nitrogen flux. The spectra were
collected in the wavenumber range from 1700 to 1600 cm1 at 1 cm1 res-
olution and smoothed using the Savitsky-Golay function after buffer and
atmospheric subtraction.TEM
The TEM pictures were taken using a FEI Morgagni 268 microscope. 5 mL
of 75-fold diluted samples were spotted on a carbon support films—300
mesh Cu grids (Quantifoil, Jena, Germany) for 30 s, washed with distilled
water, and negative stained with a 2% uranyl acetate solution.RESULTS
Aggregation kinetics
Before inducing aggregation by incubating the protein
samples at high temperature, we analyzed the initial quater-
nary structure of insulin under the investigated conditions
by SEC coupled with MALS measurements. A single peak
corresponding to a species with a molecular mass of
5800 5 100 Da was observed in the SEC chromatograms
(data reported in the Supporting Material, Fig. S2). This
value is in excellent agreement with the molecular mass of in-
sulin monomer (5808 Da), thereby indicating that under the
investigated conditions insulin is initiallypresent asmonomer.
The formation of the aggregates was monitored by ThT
fluorescence assay and by DLS, whereas the monomer con-
version was measured by SEC. The time evolution of the
SEC chromatograms is reported in the Supporting Material
(Fig. S3).
The ThT fluorescence values and the monomer conver-
sion during the aggregation kinetics of a 5 g/L (860 mM)
insulin solution with 100 mM NaCl or Na2SO4 are shown
in Fig. 1, a and b, respectively. ThT fluorescence assay is
a common technique applied to monitor the formation of
amyloid fibrils (64), which relies on the increase of the fluo-
rescence yield of the dye upon binding to b-sheet structures.
In the presence of sodium chloride the time evolution of
the ThT signal shown in Fig. 1 a exhibits the sigmoidal pro-
file commonly observed during the in vitro aggregation of
several amyloidogenic proteins: a lag-phase is followed by
rapid growth until a plateau corresponding to monomer
depletion is reached (56). The amount of soluble monomer
as a function of time decreases according to a specular
sigmoidal profile, being negligible during the lag-phase
and decreasing rapidly during fibril growth until complete
conversion is reached. This result indicates that essentially
all the converted monomers are present in the form of fibrils
characterized by b-sheet structures that are able to bind ThT.
In analogy with the behavior in the presence of sodium
chloride, also in the presence of sodium sulfate the time evo-
lution of the ThT fluorescence follows a sigmoidal profile,
as shown in Fig. 1 b. However, in contrast with the situation
with sodium chloride, after 6 h incubation ~20% of mono-
mer conversion is observed despite the ThT fluorescence
signal is still in the background noise level (Fig. 1 b). In
addition, the increase of ThT fluorescence during time
in the presence of sodium sulfate is slower than in the pres-
ence of sodium chloride. The results suggest that sulfate in-
duces a first aggregation step leading to non-ThT-binding
aggregates, which depletes ~20% of the monomer. This
aggregation step is then followed by the formation of aggre-
gates with amyloid-like content (see also Fig. S4).
To confirm the initial aggregation step in the presence
of sulfate, we followed the aggregation kinetics by DLS
(Fig. 1 c). The ThT assay is unable to detect the formation
of aggregates lacking b-sheet structures. In contrast, lightBiophysical Journal 107(1) 197–207
0 10 20 300
20
40
60
80
100
0
0.5
1
1.5
2
2.5
x 105
0 2 4 60
200
400
600
800
1000
1200
T
hT
 Fluorescence [a.u.]
Cl-
Time [h]
SO42-
SO42- Cl-
a
b
c
0 20 300
20
40
60
80
100
120
10 0
2
4x 10
5
3.5
T
hT
 Fluorescence [a.u.]
R
es
id
ua
l m
on
om
er
 [%
]
<D
h>
 [n
m
]
R
es
id
ua
l m
on
om
er
 [%
]
Time [h]
Time [h]
SO42-
FIGURE 1 Insulin aggregation kinetics in the presence of chloride and
sulfate anion. Time evolution of the ThT fluorescence values (-) and
of the residual monomer amount evaluated by SEC technique (;) for a
5 g/L (860 mM) insulin solution at pH 1.6 and 60C with (a) 100 mM
NaCl or (b) 100 mM Na2SO4; (c) average hydrodynamic diameter
measured by DLS for a 5 g/L (860 mM) insulin solution at pH 1.6 and
60C with 100 mM NaCl (:) or Na2SO4 (). To see this figure in color,
go online.
200 Owczarz and Arosioscattering techniques are sensitive to the formation of aggre-
gates independently of the morphology. The results reported
in Fig. 1 c show that in the presence of NaCl the DLS signal
increases after ~5 h, in correspondence with the increase of
ThT fluorescence (Fig. 1 a), indicating that all the aggre-
gates formed in the presence of sodium chloride contain am-
yloid structures Conversely, in the presence of sulfate the
DLS signal increases already after 1 h of incubation, indi-
cating the formation of aggregates in the micron size range
and confirming the monomer conversion measured by SEC.
The formation of these aggregates is not accompanied by an
increase of the ThT signal, which increases only after 5 h of
incubation. This result confirms that in the case of sulfate
the formation of ThT-binding aggregates is preceded by
the appearance of aggregates that are not able to bind ThT.Biophysical Journal 107(1) 197–207The effect of temperature on the aggregation kinetics in the
presence of both salts has been analyzed in the temperature
range 57–63C. This small range of temperatures has been
selected to analyze the aggregation kinetics without chang-
ing the aggregationmechanismor the aggregatemorphology,
which are strongly affected by the initial temperature value.
The fibril formationmeasured byThTassay and the time evo-
lution of the monomer conversion at different temperatures
are shown in Fig. 2. In the investigated temperature range
in the presence of chloride the kinetics are only slightly
affected by the initial temperature value and, as expected,
they increase as temperature increases (Fig. 2, a and c). In
contrast, in the presence of sulfate the kinetics are signifi-
cantly affected by the initial temperature value: a difference
of 3 induces a difference in the lag-phase of several hours
(Fig. 2, b and d). The monomer depletion corresponding to
the initial aggregation step is independent of the temperature
and equal to ~18–20%.
On the basis of these observations, we conclude that in
the presence of sulfate two different aggregation processes
occur: i), an initial aggregation step that consumes ~18–
20% of the initial monomer and leads to the formation of
amorphous aggregates; and ii), a second aggregation phase
that forms ThT-binding structures. This second aggregation
process leading to amyloid-like structure is strongly affected
by temperature, and is therefore characterized by larger
activation energy with respect to the fibrillation process in
the presence of sodium chloride.
To support the hypothesis of the formation of two popu-
lations of aggregates characterized by different structures,
in addition to ThT binding assay, which provides indirect
information about the b-sheet content of the aggregates,
we investigated the aggregate morphology at different times
by FTIR and TEM.Aggregate morphology
The FTIR spectra of samples taken at different time points
during the aggregation reaction are shown in Fig. 3, a and
b. In the presence of both chloride and sulfate at time
0 the FTIR spectrum exhibits a peak with maximum inten-
sity at the wavenumber 1656 cm1, characteristic of the
a-helix content of the protein. In the presence of chloride
after 6 h of incubation the position of the peak shifts toward
1632 cm1, corresponding to the rich amount of intermolec-
ular b-sheet structures of amyloid fibrils. This observation is
consistent with the formation of fibrils monitored by ThT
fluorescence (Fig. 1 a) and the almost complete monomer
conversion measured by SEC at 6 h incubation (Fig. 1 a).
Further analysis by TEM imaging confirms the presence
of amyloid fibrils as unique final product (Fig. 3 c).
In the presence of sulfate, the FTIR spectrum of the
sample collected after 12 h of incubation is similar to
the spectrum of the initial monomeric solution (Fig. 3 b).
The absence of b-sheet structures is in agreement with the
a b
c d
FIGURE 2 Temperature dependence of the ag-
gregation kinetics. Time evolution of ThT fluores-
cence values with (a) 100 mM NaCl or
(b) 100 mM Na2SO4 and of the residual monomer
amount with (c) 100 mM NaCl or (d) 100 mM
Na2SO4 for a 5 g/L (860 mM) insulin solution at
pH 1.6 and different temperatures: 57C (:),
60C (), and 63C (-). When nonvisible error
bars are smaller than the symbols. To see this figure
in color, go online.
Sulfate Delays Insulin Aggregation 201corresponding low ThT fluorescence value (Fig. 1 b).
Considering that after 12 h of incubation ~25% of the initial
monomers is already converted into aggregates (Fig. 1 b),
the FTIR analysis supports the hypothesis that the sulfate
anion induces an initial precipitation of amorphous aggre-
gates characterized by a secondary structure content that
is similar to the initial monomeric insulin. The FTIR spec-
trum corresponding to 74% conversion shows a larger
amount of b-sheet structures (Fig. 3 b), in agreement with
the increase of ThT fluorescence (Fig. 1 b), confirming
that the initial precipitation of amorphous aggregates is
followed by the formation of amyloid-like structures. How-
ever, in the presence of sulfate, the samples corresponding
to high conversion values retain a large amount of a-helix
content together with intermolecular b-sheet structures, sug-
gesting a different morphology of the final aggregates with
respect to the fibrils produced in the presence of sodium
chloride. The polymorphism of the aggregates obtained in
the presence of sulfate is confirmed by the TEM pictures
of samples taken after 30 h of incubation (Fig. 3, d and e):
the images show the presence of both fibrils and amorphous
aggregates. Moreover, the fibrils obtained in the presence of
sulfate anion are shorter and more branched than the fibrils
produced in the presence of chloride anion (Fig. 3, c and d).
The behavior described previously is confirmed by the
analysis of the time evolution of the aggregate morphology
obtained at different temperatures. In Fig. 3 f, we report the
wavenumber corresponding to the maximum intensity in
the FTIR spectrum as a function of monomer conversion.
The data corresponding to the different temperature values
overlap on a single curve. This result indicates that despite
the aggregation kinetics differ significantly at different tem-peratures (Fig. 2, b and d), the aggregation mechanism is un-
affected: at low conversion values insulin forms amorphous
aggregates with a-helix content and a maximum peak in the
FTIR spectrum in the range from 1650 to1656 cm1. At
conversion values larger than 50% these aggregates evolve
to b-sheet structures characterized by a maximum peak
in the FTIR spectrum at ~1633 cm1. The FTIR results
are in excellent agreement with the ThT measurements, as
shown in Fig. 3 g: the increase of ThT fluorescence with
increasing conversion occurs simultaneously to the shift of
the maximum peak in the FTIR spectra from 1655 cm1
to 1633 cm1.
To investigate further the structure transition, we isolated
by centrifugation the amorphous aggregates produced af-
ter 18% of monomer conversion (sample I in Fig. 4 a)
and we analyzed both the precipitated aggregates and the
supernatant.
The supernatant contains monomeric proteins that after a
few minutes reform the amorphous aggregates at the same
amount of 18–20%, indicating that these aggregates are in
equilibrium with the monomers. TEM images of the isolated
aggregates (Fig. 4 a) confirm the amorphous morphology of
the aggregates detected by ThT and FTIR analysis.
We then investigated the stability of these amorphous
aggregates in the absence ofmonomers by incubating the iso-
lated aggregates at 60C in the presence of 10 mM ThT.
Notably, the ThT fluorescence increases during incubation
time, as shown in Fig. 4 b, indicating structure rearrange-
ments that lead to the formation of b-sheet structures able
to bind ThT. It is interesting to note that the final ThT value
is comparable but slightly smaller than the ThT fluorescence
value corresponding to a sample with the same amount ofBiophysical Journal 107(1) 197–207
a b
c d e
f g
FIGURE 3 Change of the aggregate morphology during the aggregation reaction. (a and b) FTIR spectra of 5 g/L (860 mM) insulin samples collected at
different time points during aggregation at 60C in 25 mM HCl at pH 1.6 with (a) 100 mM NaCl or (b) 100 mM Na2SO4. (c–e) TEM pictures of the final
aggregates formed in the presence of (c) 100 mM NaCl and (d and e) 100 mM Na2SO4. In the presence of sulfate both fibrils (d) and amorphous aggregates
(e) are observed. (f) Position of the maximum intensity in the FTIR spectra and (g) ThT fluorescence values at different temperatures (57C (:), 60C (),
and 63C (-)) as a function of the monomer conversion during the aggregation of 5 g/L (860 mM) insulin in 25 mM HCl with 100 mM Na2SO4 at pH 1.6.
To see this figure in color, go online.
202 Owczarz and Arosiomature amyloid fibrils produced under the same conditions
but with 100 mM NaCl instead of sulfate (star symbol in
Fig. 4 b). The structure rearrangement of the amorphous
aggregates is confirmed by FTIR analysis, which shows the
presence ofb-sheet structures after incubation at 60C (insets
in Fig. 4, a and b). In addition, we tested the reactivity of the
aggregates before and after incubation by performing seeded
kinetic experiments (Fig. 4 c). The amorphous aggregates
have essentially no effect on the aggregation kinetics withBiophysical Journal 107(1) 197–207respect to unseeded conditions. Conversely, the ordered ag-
gregates obtained after the structure rearrangements accel-
erate significantly the fibril formation.
From the robust analysis obtainedwith the different applied
techniques (ThT binding, SEC,DLS, FTIR, TEM, and seeded
kinetic experiments), we can conclude that in the presence
of sulfate the amorphous aggregates formed during the early
stages convert during time into amyloid-like structures. This
structure change is likely driven by the minimization of the
ab
c
FIGURE 4 Structure rearrangements of the aggregates formed in the
presence of sulfate. (a) Time evolution of monomer conversion of a 5
g/L (860 mM) insulin solution in 25 mM HCl with 100 mM Na2SO4 at
60C. The insets show a TEM image and the FTIR spectrum of the amor-
phous aggregates isolated by centrifugation from the sample corresponding
to 18%monomer conversion (sample I). (b) Time evolution of the ThT fluo-
rescence of the amorphous aggregates collected from sample I in (a); the
insets show a TEM picture and the FTIR spectrum of the sample at the
end of the incubation (sample II). The star symbol represents the ThT fluo-
rescence value corresponding to a sample with the same amount of mature
amyloid fibrils produced under the same conditions but with 100 mM NaCl
instead of sulfate. (c) Aggregation kinetics of solutions that were seeded
with 1% amorphous aggregates isolated during the early stages (-)
(sample I), and with 1% ordered aggregates originating from the structure
reorganization of the amorphous aggregates during incubation at 60C
in the absence of monomer (:) (sample II). Blue circles () represent
the control unseeded experiment. Aggregation conditions are the same as
in (a). To see this figure in color, go online.
Sulfate Delays Insulin Aggregation 203system free energy and could occur either internally or via
continuous release and reincorporation of the monomers
from and into the aggregates. SEC measurements of samples
taken during the incubation of the isolated aggregates at high
temperature show no monomer in the system (data not
shown). However, rapid exchange of monomers, which is
out of the detection limit of the SEC analysis, cannot be
excluded.Effect of sulfate and insulin concentration
To investigate further the effect of sulfate on the insulin
aggregation pathway, we performed the analysis described
in the previous sections at different protein and sulfate con-
centrations. In Fig. 5, we show the aggregation kinetics fol-
lowed by ThT assay and SEC measurements at 60C. We
started our analysis by considering solutions at 100 mM
Na2SO4 and varying the insulin concentration from 0.5 to
5 g/L (86–860 mM) (Fig. 5, a and b). As expected, the aggre-
gation rate increases with increasing protein concentration.
At concentration lower than 1 g/L (172 mM) the ThT signal
after 30 h incubation is still in the background noise level,
indicating the absence of significant amount of fibrils. The
corresponding SEC measurements indicate that after 12 h
incubation ~18–20% of the monomer is consumed, and no
further aggregation occurs during the incubation time. The
relative amount of monomer converted into the amorphous
aggregates during the initial step is independent of the initial
protein concentration, and we can therefore exclude that the
formation of these aggregates is due to a solubility effect.
After analyzing the effect of insulin concentration, we
measured the aggregation kinetics at the reference insulin
concentration of 5 g/L (860 mM) changing the sulfate
concentration from 2.5 to 100 mM (Fig. 5, c and d). The
corresponding values of the lag-phase and of the half-time
measured by means of ThT fluorescence assay are reported
in Table 1.
The rate of the aggregation process decreases with
increasing the sulfate concentration. At 2.5 mM sodium
sulfate, no precipitation of amorphous aggregates is observed,
and the time evolution ofmonomer conversion andThT signal
is similar to the one observed in the presence of chloride
(Fig. 5, c and d, and Fig. 1 a). The increase of the sulfate
concentration from 2.5 to 5 mM inhibits slightly the aggrega-
tion kinetics, whereas at sulfate concentrations of 50 and
100 mM the comparison between ThTand SEC data indicate
clearly the formation of amorphous aggregates in the early
stages. In this high sulfate concentration regime, the overall
aggregation rate decreases significantly with increasing the
sulfate concentration. Based on this analysis, we can consider
the concentration of 5 mM sulfate, which, at the working
insulin concentration of 860 mM, corresponds to a sulfate/
insulin molar ratio equal to 6, as an approximate threshold
concentration above which the alternative aggregation
pathway overimposes the nucleation fibrillation pathway.Biophysical Journal 107(1) 197–207
a b
c d
FIGURE 5 Effect of protein and Na2SO4 concen-
tration on insulin aggregation in 25 mM HCl at pH
1.6 and 60C. Time evolution of ThT fluorescence
(a and c) and monomer conversion (b and d)
for: (a and b) 0.5 g/L (86 mM) (A), 1 g/L (172
mM) (◄), 3 g/L (516.6 mM) (+), and 5 g/L (860
mM) () insulin solutions with 100 mM Na2SO4;
(c and d) 5 g/L (860 mM) insulin solutions with
2.5 mM (-), 5 mM (;), 50 mM (:), or
100 mM () Na2SO4. To see this figure in color,
go online.
204 Owczarz and ArosioThe alternative nucleation pathwaydominates at larger sulfate
concentrations, and explains the decrease of the overall aggre-
gation rate with increasing sulfate concentration.a
bDISCUSSION
In the physiological range of salt concentrations typically
considered in protein aggregation studies (0–150 mM), the
increase in the concentration of monovalent salts induces
commonly an increase of the aggregation rate, as verified
in our system by kinetic experiments in the presence of
sodium chloride (see Fig. S5). By contrast, it is found that
the increase in sulfate concentration has an inhibitory effect
on insulin aggregation kinetics at low pH. The results
described in the previous sections show that this effect is
associated with a change in the insulin aggregation pathway
with increasing the sulfate concentration.
At low sulfate concentrations (0–5 mM) insulin aggrega-
tion follows a nucleation polymerization mechanism, which
forms amyloid fibrils. This mechanism has been widely
described in the literature in the presence of monovalent
anions (47,51,52,55–58,60–63,65) (Pathway 1 in Fig. 6).TABLE 1 Lag-phases and half-times (t50) of the aggregation of
a 5 g/L (860 mM) insulin solution in 25 mM HCl at pH 1.6 and
60C at different sodium sulfate concentrations as measured
by ThT fluorescence assays
SO4
2- Conc. [mM] Lag time [h] t50 [h]
100 7.2 12.0
50 5.8 10.6
5 4.3 6.0
2.5 4.2 5.0
Biophysical Journal 107(1) 197–207At sulfate concentrations larger than ~5 mM, ~18–20% of
the insulin monomers are initially converted into reversible
amorphous aggregates (Pathway 2 in Fig. 6). When these
amorphous aggregates are removed from the solution, they
are reformed in a few minutes at the same amount of
18–20% of the total protein concentration, indicating that
the aggregates are in equilibrium with the monomers.
During incubation, these aggregates undergo structureFIGURE 6 Schematic diagram showing the alternative aggregation
mechanisms of insulin in the presence of sulfate. (a) At low sulfate concen-
trations (0–5 mM) insulin forms amyloid fibrils following the nucleated
polymerization mechanism commonly observed under acidic conditions
in the presence of monovalent anions; (b) When the sulfate concentration
is increased above 5 mM, the sulfate anion induces the salting-out of
~18–20% of insulin molecules into reversible amorphous aggregates that
retain a large content of a-helix structures. During time, these aggregates
undergo structure rearrangements into polymorphic species that exhibit
b-sheet structures. To see this figure in color, go online.
Sulfate Delays Insulin Aggregation 205reorganization from a-helix to b-sheet structures, which are
able to bind ThT dye and act as seeds that recruit soluble
monomers. The aggregation process in the presence of sul-
fate is characterized by larger activation energy with respect
to the aggregation in the presence of chloride. This larger
activation energy may be related to either the structure rear-
rangements of the amorphous aggregates or the elongation
reaction between monomeric proteins and the seed-compe-
tent aggregates.
Not only the aggregation pathway but also the mor-
phology of the final aggregates obtained in the presence of
the two anions is different. Although the final value of the
ThT signal is comparable for the two anions (Fig. 1, a and
b), the TEM pictures show different macroscopic structures
of the final aggregates: in particular, in the case of chloride
anion only fibrils are detected (Fig. 3 c), whereas in the
presence of sulfate anion both fibrillar and amorphous
aggregates are observed (Fig. 3, d and e). These results
are consistent with the FTIR analysis of the final aggregates,
which shows a mixture of a-helix and b-sheet structures
in the case of sulfate and reveals the presence of b-sheet
structures in the case of chloride (Fig. 3).
The alternative aggregation mechanism in the presence
of sulfate, which has been characterized in detail in this
kinetic study, is in agreement with previous findings re-
ported in the literature, which show a different morphology
of insulin aggregates obtained in the presence of sulfate
(38,56,66).
The microscopic mechanism responsible for the forma-
tion of the amorphous aggregates is likely due to a combina-
tion of the peculiar binding and salting-out properties of the
sulfate anion. Sulfate anion has a large propensity to bind to
insulin molecules (38) and to induce salt bridges (40,67). It
has been recently demonstrated that, even at low salt con-
centrations (few to 10 mM), ion-binding and additional
ion-specific effects, on top of the Debye-Hu¨ckel charge
screening effect, modify protein electrostatic interactions
and aggregation kinetics (20). It is expected that at larger
salt concentrations (10–100 mM) the ion binding, together
with the salting-out effect, can affect even more signifi-
cantly both the protein structure and the intermolecular
interactions.
According to circular dichroism analysis, the presence of
sulfate does not modify either the initial protein structure or
the thermal stability with respect to sodium chloride (data
reported in the Supporting Material, Fig. S6), although
small changes not detectable by circular dichroism cannot
be excluded.
The reduction of insulin net charge upon binding,
together with the increase of hydrophobic interactions due
to preferential exclusion, increases the net attractive inter-
molecular interactions between insulin molecules, thus pro-
moting aggregation, and in particular the nucleation of
aggregates characterized by native-like content. These ag-
gregates are likely formed too rapidly to reach the moststable configuration. The kinetically trapped species reorga-
nize during time into more thermodynamically favored
b-sheet structures, which are able to bind ThT dyes and
recruit additional monomers.
The system described in this work shows how the kinetic
and the thermodynamic features of the protein aggregation
process are highly sensitive to the environmental parame-
ters, which affect the intra- and intermolecular interactions
driving the microscopic aggregation events and the overall
reaction mechanism.
These aspects are relevant for instance in the biotech-
nology context for the development of strategies to improve
the formulation of protein-based drugs. Salt-induced aggre-
gation of proteins in aqueous solutions is a major problem
that is often encountered during the production and the stor-
age of therapeutic proteins. The results shown in this work,
although obtained under strong denaturing conditions, may
suggest some caution in the use of sulfate and sulfonated
compounds in the processing and formulation of insulin,
because these compounds can rapidly trigger the formation
of amorphous precipitates, which cannot be detected by ThT
fluorescence assay and can convert slowly into ordered
aggregates with seeding properties.
In the context of protein aggregation involved with
human diseases, it remains challenging to understand at a
fundamental level the interactions between proteins and
all the possible cellular components. On a long term, the
results obtained on the effect of sulfate on in vitro pro-
tein aggregation may represent a first step toward the
understanding of the complex in vivo interactions be-
tween proteins and sulfonated macromolecules such as
glycosaminoglycans.CONCLUSIONS
In this study, we investigated the effect of sulfate anion on
the kinetics and the mechanism of insulin aggregation at
low pH. It is found that the increase of sulfate concentration
inhibits insulin aggregation kinetics.
This effect is associated with a change in the aggregation
mechanism with increasing sulfate concentration. At low
sulfate concentrations (0–5 mM) insulin monomers form
amyloid fibrils following the nucleated-polymerization
mechanism commonly observed with monovalent anions.
At sulfate concentrations larger than 5 mM, an alternative
aggregation mechanism is observed: initially, 18–20% of
monomers are converted into reversible aggregates that
retain a large amount of native a-helix structure. During
time, according to FTIR, ThT binding, and seeded kinetic
assays, these intermediate amorphous aggregates undergo
reorganization into b-sheet structures, which are able to
bind to the ThT dye and seed fibril formation. TEM analysis
shows that the final aggregates consist of a mixture of amor-
phous and fibrillar aggregates, and differ from the regular
amyloid fibrils obtained in the presence of chloride.Biophysical Journal 107(1) 197–207
206 Owczarz and ArosioThe system characterized in this work represents a case
where amorphous aggregates on-pathway to the formation
of structures with amyloid-like content could be detected
and characterized.SUPPORTING MATERIAL
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